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Table 1 Showing plain CT imagin
Imaging ﬁndings Diﬀeren
granula
choleste
Middle ear lesions
Granulation tissue (10) –
1ry cholesteatomas (21) –
2ry cholesteatomas (11) –
Sensitivity (lesions detection): 1.00 [0.8
Speciﬁcity (lesions characterization): 0
10 S.A. El Mogy et al.two radiologist analyzed the imaging data of plain spiral CT and PROPELLER diffusion MR
images. Sensitivity and speciﬁcity were assessed. Results were compared with endoscopic and sur-
gical results, which were regarded as the standard reference.
Results: Ten patients had middle ear granulation tissue, 21 patients had acquired primary choleste-
atomas, and 11 patients had acquired recurrent (post operative) cholesteatomas. PROPELLER dif-
fusion MR successfully diagnosed and differentiated between granulation tissue and cholesteatomas
(primary and recurrent. Sensitivity (lesions detection) and speciﬁcity (lesions characterization) of
PROPELLER diffusion MR was 100%. In recurrent cholesteatomas, plain CT detected abnormal
densities without any differentiation resulting in 0% speciﬁcity while in primary cholesteatomas, CT
successfully diagnosed them based on associated bone erosions/destruction.
Conclusion: PROPPLER diffusion Imaging is both sensitive and speciﬁc for detection and charac-
terization of primary and recurrent cholesteatomas as it lack susceptibility and chemical-shift arti-
facts, and ghosts in the phase-encoding direction which occur in Echo-planar diffusion, it can detect
small cholestatoma as 3 mm. It provides the highest sensitivity, speciﬁcity for detection and char-
acterization of acquired cholesteatomas.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Cholesteatoma is a cystic lesion lined with keratin-producing
squamous epithelium ﬁlled with desquamation debris in the
middle ear, mastoid air cells, or petrous apex. Patients are trea-
ted surgically, but the procedure carries the risk of residual
cholesteatoma and recurrence. The detection of cholesteatoma
in patients who have undergone middle ear surgery using oto-
scope is often difﬁcult. Therefore, second-look operations are
frequently performed [1–4].
Imaging of cholesteatomas can be problematic especially
in cases of recurrent disease. Computed tomography scans
have been recommended before primary surgery, but choles-
teatoma tissue looks similar to inﬂammatory tissue [5–7].
Non-enhanced magnetic resonance imaging (MRI) shows
less detail of the temporal bone than CT. Enhanced scanning
using gadolinium contrast, following a 45-minute delay, gran-
ulation tissue gives a hyperintense signal, whereas cholestea-
toma, being avascular, does not enhance at all and can
therefore be distinguished from other tissues. However, this
is very time-consuming, and gadolinium is also known to occa-
sionally cause side effects [11–15]. In echo-planar diffusion-
weighted MRI scans cholesteatoma is seen as a hyperintense
signal, distinguishing it from other middle-ear and mastoid
structures. This imaging modality is therefore useful for diag-
nosis of primary or recurrent cholesteatoma when the clinical
diagnosis is uncertain, and also for the postoperative detection
of residual cholesteatoma following canal wall up mastoidec-
tomy [16–18].g features of our patients.
tiation between
tion tissue and
atoma
Ossicular ch
bone erosion
–
+ve in all
Post operativ
1; 1.00]. . ..100%.
.50 [0.34; 0.66]. . ..50%.Unfortunately susceptibility artifact occurs in echo-planar
diffusion, when bone and air occur next to each other, a higher
intensity MRI signal is produced, termed a susceptibility arti-
fact. Where the temporal lobe lies adjacent to the temporal
bone and the mastoid air space, a characteristic high intensity
curvilinear artifact is often seen. As this is an area in which
cholesteatomas can form, differentiation between susceptibility
artifact and cholesteatoma can be difﬁcult, making accurate
diagnosis of small cholesteatomas problematic. There is also
the risk of false positives, when the artifact is mistaken for cho-
lesteatoma, and false negatives, when the cholesteatoma is hid-
den in the hyperintense artifact signal [8–10].
Periodically rotated overlapping parallel lines with en-
hanced reconstruction (PROPPLER) diffusion is a spin echo
diffusion-weighted image, scans give images free from suscep-
tibility artifacts. This means that small cholesteatomas as
4 mm can be detected as a bright, hyperintense signal diagnos-
tic of cholesteatoma [19–22].
Aim of the work was to evaluate the role of periodically ro-
tated overlapping parallel lines with enhanced reconstruction
(PROPELLER) diffusion imaging in evaluation of middle ear
acquired cholestatomas (primary and recurrent: post operative)
and differentiating them from middle ear granulation tissue.2. Patients and methods
This prospective study conducted at a private center in
Mansoura, Egypt from the period of February 2010 tillain and
s or destruction
Complications
(temporal lobe meningitis:3,
inner ear ﬁstula:2)
Mastoiditis
– +ve in all
+ve (5) +ve in all
e changes – +ve in all
Table 2 Showing imaging features using PROPELLER dif-
fusion scan combined with conventional MRI.
Imaging ﬁndings middle ear lesions Hyperintense signal
Granulation tissue (10) –
1ry cholesteatomas (21) +ve in all
2ry cholesteatomas (11) +ve in all
Sensitivity (lesions detection): 1.00 [0.81; 1.00]. . ..100%.
Speciﬁcity (lesions characterization): 1.00 [0.81;1.00]. . ..100%.
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Graph 1 Showing lesions characterization by the plain spiral CT
and PROPELLER diffusion MR imaging.
Evaluation of acquired cholesteatoma with PROPELLER diffusion imaging 11January 2011, it contained 42 patients: 32 with acquired mid-
dle ear cholesteatomas and 10 with middle ear granulation/
inﬂammatory tissue. They were 23 females, 19 males, their ages
ranged from 12 to 53 years with a mean of 32.5 years.
Patients referred from oto-rhino-laryngology clinic of
Mansoura University hospital on the bases of suspected ac-
quired cholesteatomas whether primary or recurrent. The 32
acquired cholesteatomas were classiﬁed into: primary choleste-
atomas: 21 patients and recurrent (post operative) cholesteato-
mas: 11 patients. Among the 32 patients of cholesteatomas, 7
were bilateral and the remaining 25 were unilateral.Figure 1 (A–G) Patient aged 27 years with primary acquired RT. Ch
(abscess). (A) Axial T2FSE showing RT. Middle ear soft tissue mass (lo
collection (arrow head). (B and C) early post contrast axial and coronal
with non enhancing middle ear soft tissue mass and mastoiditis. (D) E
base. (E) PROPELLER diffusion showing hyperintense signal at RT. M
and G) Coronal and sagittal PROPELLER diffusion sowing RT middAll patients performed spiral CT of petrous bone. Axial
and coronal images were taken with the following parameters:
KV;120/mAm:160–200/WW:2740/WL:376/thickness:
1.25 mm.
All patients performed MRI using 1.5 T GE medical sys-
tem. Sequences obtained were the following: GRE scout (axial,
coronal, sagittal), and periodically rotated overlapping parallelolesteatoma complicated with RT. Extra axial cerebeller collection
ng arrow), mastoiditis (short arrow) and RT. Extra axial cerebellar
T1WI: showing thickened enhanced cerebellar meningese (arrows)
cho-planar diffusion showing susceptibility artifacts near the skull
iddle ear + extra axial abscess with no susceptibility artifacts. (F
le ear cholesteatoma and extra axial cerebellar abscess.
Figure 2 (A–D) Patient aged 30 years with primary LT cholesteatoma. (A and B) axial and coronal CT scan showing LT. middle ear
(epitympanum) soft tissue density with ossicular rariﬁcation (arrows). (C) Axial T2WI FSE showing hyperintense signal at LT middle ear
(arrow). (D) PROPELLER DWI showing hyperintense signal at LT. Middle ear conﬁrming the diagnoses of recurrent cholesteatoma.
Figure 3 (A–G) Patient aged 36 years with bilateral primary cholesteatomas. (A and B) Axial and coronal CT scan showing bilateral
middle ear soft tissue densities. (C) Axial T2FSE showing bilateral middle ears abnormal signal intensity. (D and E) PROPELLER
diffusion images showing bilateral hyperintense signal at both middle ears consistent with bilateral cholesteatomas. (F and G) Sagittal
PROPELLER diffusion images. (E) Showing RT. Cholesteatoma, (F) LT. Cholesteatoma.
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Evaluation of acquired cholesteatoma with PROPELLER diffusion imaging 13lines with enhanced reconstruction (PROPPLER) diffusion
sequence.2.1. Parameters of PROPELLER diffusion
TR/TE:7000/105/FOV:22 · 22, matrix; 128 · 128/NEX:2/
thickness; 4 mm/acquisition time:4 min + 35 s. Axial images
were taken then coronal and sagittal reformat were done.
Correlation with endoscopic and surgical ﬁndings were
done for all patients.2.1.1. Image analysis
The two radiologists worked independently, analyzed the
images using a workstation (Advantage Windows, GE Health-
care). Observers assessed CT images for middle ear abnormal
density, ossicular chain destruction/erosions, scutum and tyg-
men tympani erosions, semicircular canal ﬁstulation, mastoid
air cells, and facial nerve canal.
PROPELLER diffusion images were assessed for presence
of middle ear hyperintense lesion (cholestatoma) opposite the
black back ground.
Approval of the ethical committee was taken. Written con-
sent was obtained from adult patients or parents of pediatric
patients.Figure 4 (A–E) Patient aged 21 years with LT. Acquired primary
(A and B) axial CT images showing bilateral middle ear soft tissue den
signals. (D & E) PROPELLER diffusion images showing LT. Middl
tissue.2.1.2. Statistical analyses
The statistical analysis of data done by using excel program
and SPSS (SPSS, Inc, Chicago, IL) program statistical package
for social science version 16.
The description of the data done in form of mean (+/)
SD for quantitative data. And frequency and proportion for
qualitative data.
The analysis of the data was done to test statistical signiﬁ-
cant difference between groups.
Paired sample t-test to compare one group at different time.
Chi square test was used for qualitative data.
N.B: P is signiﬁcant if 60.05 at conﬁdence interval 95%.
4. Results
Our study contained 42 patients, 10 had granulation tissue, 21
had primary cholesteatoma and 11 had recurrent post opera-
tive cholesteatoma. Regarding plain CT, all patients showed
soft tissue density at middle ear. Ossicular chain erosions/
destruction was found in the 21 patients having primary cho-
lesteatoma, all patients had mastoiditis. Facial nerve canal
was normal in all patients. Five patients of primary cholestea-
toma had complications in the form of: 3 temporal lobe and
cerebellar meningitis and extra axial collections and 2 inner
ear ﬁstula. Only bone erosions diagnosed primary cholestea-cholesteatoma. Patient complained from bilateral ear discharge.
sities. (C) Axial T2FSE showing bilateral middle ear hyperintense
e ear cholesteatoma. Endoscopy of RT. Ear revealed granulation
14 S.A. El Mogy et al.toma. Recurrent cholestatoma cannot be diagnosed from CT
as there were no ossicular chain.
Imaging features of CT were shown at Table 1.
All patients performed PROPELLER diffusion MRI. It
successfully identiﬁed cholesteatomas in all the 32 patients,
patients showed hyperintense signal at the region of middle
ear with no susceptibility artifacts. Patients with granulation
tissue did not show any hyperintense signal. Imaging features
of cholesteatoma by PROPELLER diffusion scan were shown
in 2Table 2.
Lesions characterization by plain CT and PROPELLER
diffusion MR are shown on Graph 1.
5. Discussion
In cholesteatomas, computed tomography (CT) scans are used
to identify bony structures such as ossicles, lateral semicircular
canals and the facial nerve canal. Some otologists use these
images before operating to familiarize themselves with any
anatomical variation. However, CT differentiates poorly be-
tween different soft tissues and as such is less useful for choles-
teatoma diagnosis. Granulation tissue, scar tissue, cholesterol
granulomas and oedematous mucosa can all be mistaken forFigure 5 (A–F) Patient aged 19 years with RT. Aquired primary cho
ear, mastoid abnormal signal intensities. (C) Coronal FLAIR show
diffusion MRI showing susceptibility artifacts at the region of petrous
clearly demonstrate RT. Middle ear cholesteatoma.cholesteatoma on CT scanning, and vice versa. In CT images
showing bony erosion, cholesteatoma is likely the diagnoses,
in cases with previous mastoid surgery the anatomy will have
been altered at the initial operation, and the diagnosis is more
difﬁcult [5–7,11].
In the current study, plain CT successfully evaluated bony
structures of the middle ear, it demonstrated ossicular ero-
sions/destruction in all primary cholesteatoma patients, it also
showed erosions of tygmen tympani with subsequent meningi-
tis and extra axial collections in three patients, also showed in-
ner ear ﬁstula in 2 patients, however it didn’t differentiate
between cholesteatomas and granulation tissue (Table 1).
MR imaging is able to discriminate the non enhancing
cholesteatoma from enhancing inﬂammatory or granulation
tissue. Several reports have discussed the appearance of ac-
quired cholesteatoma on EPI-DWI images, cholesteatomas
demonstrate a hyperintensity probably based on a T2 shine-
through effect [23–25]. However, a major limitation of the
EPI-DWI images still seems to be the important susceptibil-
ity artifact at the skull base (among other artifacts), the low
resolution, and relatively thick sections, thus causing a size
limit for detection on EPI-DWI of approximately 5 mm.
[26–29].lesteatoma. (A and B) Axial T2FSE, T1FSE showing RT. Middle
ing RT. Middle ear abnormal signal intensity. (D) Echo-planar
bone. (E and F) Axial and coronal PROPELLER diffusion images
Evaluation of acquired cholesteatoma with PROPELLER diffusion imaging 15The ability of DWI to be used consistently to evaluate the
temporal bone is hindered by image distortion caused by suscep-
tibility artifacts, chemical-shift artifacts, and ghosts in the phase-
encoding direction. This is due to the high bone attenuation of
the inner ear and the numerous air-bone interfaces present with-
in the mastoid air cells and the middle ear cavity [30–31].
With Multishot fast spin-echo (SE) periodically rotated
overlapping parallel lines with enhanced reconstruction PRO-
PELLER MR imaging, the marked reduction in off resonance
artifacts is primarily caused by the type of sequence (fast SE):
Fast SE imaging is less sensitive to changes in the constant
magnetic induction ﬁeld, because of multiple 180 refocusingFigure 6 (A–G) Patient aged 33 years with recurrent RT. Cholesteat
levels showing RT. Middle ear soft tissue density. Note post operative
middle ear cavity (arrow). (D and E) Axial T2FSE at different levels sho
G) PROPELLER diffusion images showing hyperintense signal at RTpulses. Reduction of susceptibility artifacts is particularly
important for adequate visualization of the middle ear [12].
PROPELLER DWI presents a better contrast and reduces
artifacts. PROPELLER is a multishot fast SE acquisition and
is based on special methods that results in an over sampling of
the center of the k-space, providing a more signal-intensity-
rich image, removes structured motion artifacts, and enables
the reduction of bulk patient motion artifacts [22].
In the current study, PROPELLER diffusion sequence suc-
cessfully diagnosed all cases of cholesteatomas whether primary
or secondary, it successfully differentiated cholesteatomas from
granulation tissue, cholesteatomas showed hyperintense signaloma. (A–C) Axial (A and B) and coronal (c) CT scan at different
changes in the form of connection of RT. Mastoid air cells with
wing RT. Middle ear + mastoid abnormal signal intensity. (F and
. Middle ear consistent with RT. Cholesteatoma.
16 S.A. El Mogy et al.while granulation tissue showed hypointense signal (Table 2),
(Figs. 1–6).
In the study of E. Flook et al., 2011, using echo-planar dif-
fusion-weighted MRI they detected cholesteatomas as small as
4 mm, they reported that the detection of smaller cholesteato-
mas may also be possible.
P.Lehman et al., 2009 reported that the smallest recurrent
cholesteatoma diagnosed by PROPELLER diffusion was
3 mm and was surgically proved.
In the current study the smallest cholesteatoma detected
was 3 mm (primary) which was surgically proved and
removed.
Delayed post contrast MR imaging is able to discriminate
the non enhancing cholesteatoma from enhancing inﬂamma-
tory or granulation tissue, however it’s cost and probable side
effects limits it’s use [28].
In the study of Aikele et al., 2003 Echo-planar diffusion-
weighted MR imaging combined with conventional MR imag-
ing depicted 10 of 13 cholesteatomas (sensitivity, 77%). The
three lesions that were missed were smaller than 5 mm. All
the MR images of patients without cholesteatoma were cor-
rectly interpreted as showing negative ﬁndings for cholestea-
toma (speciﬁcity, 100%). The positive predictive value and
negative predictive value were 100% and 75%, respectively).
Jindal et al., 2010 stated that echo-planar diffusion
weighted imaging demonstrated a sensitivity of 83% and a
speciﬁcity of 82% in the diagnosis of residual cholesteatoma.
In the study of Lehman et al., 2009, he reported that PRO-
PELLER provides the heights sensitivity (100%), speciﬁcity
(100%), PPV (100%) and NPV (100%), for all the observers
with a signiﬁcant difference compared to echo planar diffusion
(36.1%, 100%, 100%, 58.2%, respectively) and post contrast
MRI (91.2%, 81.2%, 84.5%, 89.2%), respectively (for observ-
ers 1,2).
In the current study sensitivity (lesions detection) and spec-
iﬁcity (lesions characterization) of PROPELLER diffusion was
100% as it successfully detected, characterized the lesions. In
recurrent cholesteatomas, plain CT detected abnormal densi-
ties but with out any differentiation (Fig. 6), CT detected 21
patients (50%) with primary cholesteatoma from associated
bone erosions (Figs. 1–5).
The principal limitation of our study was PROPELLER
scan time: 4 min + 35 s, hoping in the near future the ad-
vanced technology can decrease scan time.6. Conclusion
PROPPLER diffusion Imaging is both sensitive and speciﬁc
for detection and characterization of primary and recurrent
cholesteatomas as it lack susceptibility and chemical-shift arti-
facts, and ghosts in the phase-encoding direction which occur
in Echo-planar diffusion, it can detect small cholestatoma as
3 mm. It provides the highest sensitivity, speciﬁcity for detec-
tion and characterization of acquired cholesteatomas.References
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